Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Latent Tuberculosis Infection (LTBI) Testing market size will reach 1,805.42 Million USD in 2025 and is projected to reach 2,695.03 Million USD by 2032, with a CAGR of 5.89% (2025-2032). Notably, the China Latent Tuberculosis Infection (LTBI) Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The major global suppliers of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Latent Tuberculosis Infection (LTBI) Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Latent Tuberculosis Infection (LTBI) Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Latent Tuberculosis Infection (LTBI) Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Latent Tuberculosis Infection (LTBI) Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Latent Tuberculosis Infection (LTBI) Testing Include:
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Latent Tuberculosis Infection (LTBI) Testing Product Segment Include:
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI) Testing Product Application Include:
Hospitals and Clinics
Diagnostic Laboratories
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Latent Tuberculosis Infection (LTBI) Testing Industry PESTEL Analysis
Chapter 3: Global Latent Tuberculosis Infection (LTBI) Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Latent Tuberculosis Infection (LTBI) Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Latent Tuberculosis Infection (LTBI) Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Latent Tuberculosis Infection (LTBI) Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Latent Tuberculosis Infection (LTBI) Testing market size will reach 1,805.42 Million USD in 2025 and is projected to reach 2,695.03 Million USD by 2032, with a CAGR of 5.89% (2025-2032). Notably, the China Latent Tuberculosis Infection (LTBI) Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The major global suppliers of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Latent Tuberculosis Infection (LTBI) Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Latent Tuberculosis Infection (LTBI) Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Latent Tuberculosis Infection (LTBI) Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Latent Tuberculosis Infection (LTBI) Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Latent Tuberculosis Infection (LTBI) Testing Include:
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Latent Tuberculosis Infection (LTBI) Testing Product Segment Include:
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI) Testing Product Application Include:
Hospitals and Clinics
Diagnostic Laboratories
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Latent Tuberculosis Infection (LTBI) Testing Industry PESTEL Analysis
Chapter 3: Global Latent Tuberculosis Infection (LTBI) Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Latent Tuberculosis Infection (LTBI) Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Latent Tuberculosis Infection (LTBI) Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Latent Tuberculosis Infection (LTBI) Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Latent Tuberculosis Infection (LTBI) Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Latent Tuberculosis Infection (LTBI) Testing Product by Type
- 1.2.1 Tuberculin Skin Test (TST)
- 1.2.2 Interferon Gamma Released Assay (IGRA)
- 1.3 Latent Tuberculosis Infection (LTBI) Testing Product by Application
- 1.3.1 Hospitals and Clinics
- 1.3.2 Diagnostic Laboratories
- 1.3.3 Others
- 1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Analysis (2020-2032)
- 1.5 Latent Tuberculosis Infection (LTBI) Testing Market Development Status and Trends
- 1.5.1 Latent Tuberculosis Infection (LTBI) Testing Industry Development Status Analysis
- 1.5.2 Latent Tuberculosis Infection (LTBI) Testing Industry Development Trends Analysis
- 2 Latent Tuberculosis Infection (LTBI) Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Latent Tuberculosis Infection (LTBI) Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Latent Tuberculosis Infection (LTBI) Testing Market Analysis by Country
- 4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Latent Tuberculosis Infection (LTBI) Testing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Latent Tuberculosis Infection (LTBI) Testing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Latent Tuberculosis Infection (LTBI) Testing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Latent Tuberculosis Infection (LTBI) Testing Market Analysis by Type
- 6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Qiagen
- 7.1.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Sanofi
- 7.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Oxford Immunotec
- 7.3.1 Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Thermo Fisher Scientific
- 7.4.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Par Sterile
- 7.5.1 Par Sterile Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Bio-Rad Laboratories
- 7.6.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Portfolio
- 7.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
- 8.2 Latent Tuberculosis Infection (LTBI) Testing Product Downstream Application Analysis
- 8.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Forecast by Application (2020-2032)
- 8.3 Latent Tuberculosis Infection (LTBI) Testing Typical Downstream Customers
- 8.4 Latent Tuberculosis Infection (LTBI) Testing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
